DiogenX’s website
Marseille, FR · 5 known investors
DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes. It focuses on new treatment options for diabetic patients as an alternative to lifelong exogenous insulin.
Founders & leadership
Investors · 5
Competitors · 10
by search overlapargenx6 shared keywordsThe company develops therapies for people with severe autoimmune diseases.
Gendx5 shared keywordsGenDx develops molecular diagnostic reagents, software, and services for transplant patient outcomes. Operating globally since 2005, the company serves the healthcare and diagnostics industry with specialized tools for transplant diagnostics.
Regenx Biosciences5 shared keywordsREGENXBIO is a gene therapy company developing treatments for rare and retinal diseases using its NAV Technology Platform of viral vectors, which it also licenses to other pharmaceutical and biotech companies. It operates a late-stage clinical pipeline and manufactures its investigational gene therapies at its facility in Rockville, MD.
Orogentx4 shared keywordsOrogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases. The company combines computational chemistry, DNA-encoded library technology, and medicinal expertise to develop novel therapeutic medicines.
Phigenix3 shared keywordsPhigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
Origene3 shared keywordsOriGene develops and supplies genomic and proteomic research tools, including proteins and antibodies built on its proprietary cDNA clone collections, for life science researchers. The company offers a broad catalog of research products used in scientific discovery and diagnostics development.
Bioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Genedx3 shared keywordsGeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.
Endogenex3 shared keywordsEndogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes. Developed in partnership with Mayo Clinic, the therapy aims to help patients manage blood glucose levels and slow disease progression.
Genomadix3 shared keywordsGenomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.
Companies competing with DiogenX’s website for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does DiogenX’s website do?
- DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes. It focuses on new treatment options for diabetic patients as an alternative to lifelong exogenous insulin.
- Who founded DiogenX’s website?
- DiogenX’s website was founded by Benjamin Charles, Patrick Collombat, Jean-Pascal Tranié.
- Who are DiogenX’s website's investors?
- DiogenX’s website's investors include AdBio partners, Roche Venture Fund, Boehringer Ingelheim Venture Fund, Sunstone Capital, JDRF T1D Fund.
- Where is DiogenX’s website headquartered?
- DiogenX’s website is headquartered in Marseille, FR.